Australia's largest stock trading and investment forum Australia's #1 stock forum

BLT benitec biopharma limited

0.00%

2.6¢

Ann: App 4E / Full Year Statutory Accounts, page-6

First 6 Last

Share
Profile

Follow
Hoyland

4,015 Posts.

127

31/08/15

17:49

Post #: 15907523
Share

Originally posted by SmokeyNYY ↑

Anyone notice that Hepbarna is scheduled to begin phase 1 studies before TT-221 (AMD) even though its further behind in pre-clinical?

As per the financial review-

"As both HBV and HCV replicate in the liver, Benitec has designed Hepbarna to mimic the design elements of TT-034, which could expedite Hepbarna’s regulatory pathway"

Everyone knows this is the real "lead candidate". If TT-034 works this will have a very high chance of working as well. I believe this is what we will be making a deal for with Big Pharma. I don't know how most deals go but 50% Royalties for a couple hundred million dollars sounds good to me. Cash up!!!

Expand

This statement on HBV seems a little inconsistent with that made in the last IPO prospectus. I am sure the prospectus said that the AMD program would be taken to the clinical stage but there are insufficient funds to do the same for HBV. I guess the company is expecting another capital raising in order to progress HBV.

I also note that the $2.7M for the Tribetarna trial is still in the Current Assets.

Last edited by Hoyland: 31/08/15

BLT Price at posting: 56.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

DRO

History repeats for DroneShield investors but carnage so far subdued

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

AII

A new NASDAQ listing for a key player in the global critical minerals space

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

HotCopper Highlights: Trigg; Droneshield; Lumos & more

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

First 6 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: App 4E / Full Year Statutory Accounts, page-6

Top Stories

Syrah jumps +19% as graphite tariff threat spurs optimism down under

History repeats for DroneShield investors but carnage so far subdued

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

A new NASDAQ listing for a key player in the global critical minerals space

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

Featured News